In older people, a rapamycin analogue (everolimus) improves vaccine response and TORC1 inhibition reduces infections; small sample sizes. ConfidenceDebated Level of evidence●●●●●○ Randomized clinical trial Observed inHuman MissionMap of aging (12 hallmarks) ConceptsDisabled macroautophagyRapamycin (and analogues: everolimus)mTOR (mTORC1)